NCT05892068 2026-02-13A Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the BrainMemorial Sloan Kettering Cancer CenterPhase 2 Active not recruiting9 enrolled
NCT04457596 2025-10-29T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD TrialAlliance for Clinical Trials in OncologyPhase 3 Active not recruiting1,056 enrolled